The 9th Zurich Immuno-Oncology Symposium will bring together clinicians and scientists from across the field of cancer immunotherapy to deepen the understanding of cancer, the immune system and immunotherapy.
Universitätsspital Zürich, Rämistrasse 100, 8091 Zürich
Grosser Hörsaal OST (HOER B10)
07.03.2025
08:30 - 17:15
tbd
Kostenlos
| 08:30 | Welcome Markus G. Manz & Chiara F. Magnani, University Hospital Zurich |
| 08:35 | Immuno-Epitope Shielding Pietro Genovese, Dana-Farber Cancer Institute, Boston |
| 09:00 | Genome-edited “universal” CAR T cells for childhood leukaemia Christos Georgiadis, Great Ormond Street Hospital for Children, London |
| 09:25 | Universal allo-T-cell editing Sai Reddy, ETHZ Basel |
| 09:50 | In vivo gene editing / engineering Hamideh Parhiz, Penn Institute for RNA Innovation, Philadelphia |
| 10:15 | Short Talk: Acquisition of an immunosuppressive microenvironment after CAR-T therapy drives T-cell dysfunction and resistance Chiara F. Magnani, University Hospital Zurich |
| 10:25 | Coffee Break |
| 10:40 | CLAUDIN-6 CAR-T + mRNA vaccine John B.A.G. Haanen, Leiden University Amsterdam |
| 11:05 | TCR engineered T-cells in cancer therapy Eliana Ruggiero, Università Vita-Salute San Raffaele, Milan |
| 11:30 | Combined CAR-T and gene-modified dentritic cell therapy Michele De Palma, EPFL Lausanne |
| 11:55 | Short Talk: Adaptor CAR T-cells in solid tumors Christian Pellegrino, University Hospital Zurich |
| 12:05 | Lunch Break |
| 12:35 | Adoptive cell therapy with tumor infiltrating lymphocytes (TIL) Heinz Läubli, University of Basel |
| 13:00 | CAR-NK cell therapy: current status and future perspectives Evelyn Ullrich, Faculty of Medicine at Goethe University Frankfurt |
| 13:25 | CAR-iNKT therapy Antonia Rotolo, University of Pennsylvania, Philadelphia |
| 13:50 | CAR-Macrophage therapy Nico Lachmann, Hannover Medical School |
| 14:25 | Coffee Break |
| 14:40 | Therapeutic targeting of alloreactive antigens Paresh Vyas, University of Oxford, UK |
| 15:05 | Engaging Neutrophiles in tumor immunotherapy Marjolein van Egmond, Amsterdam UMC |
| 15:30 | Bispecific T-cell engagers in solid tumors / prostate cancer Helmut Salih, University Hospital Tübingen |
| 15:55 | Precision gene delivery for tumor therapy Andreas Plückthun, University of Zurich |
| 16:20 | The present and future of bispecific antibodies for cancer therapy Christian Klein, Curie.Bio, Zurich |
| 16:45 | Short Talk: Therapeutic response to checkpoint inhibitors in melanoma patients Mitchell P. Levesque, University Hospital Zurich |
| 16:55 | Wrap-Up Markus G. Manz, University Hospital Zurich |
Bitte melden Sie sich bis zum 06.03.2025 an.
Please register by 07.03.2025.